Rituximab in treatment-resistant anti-HMG-CoA reductase immune-mediated necrotising myopathy
Neurología (English Edition)
· Elsevier
Аннотация
Publication date: October 2026 Source: Neurología (English Edition), Volume 41, Issue 8 Author(s): A. Pato-Pato, L.M. López-Díaz, L. Herrero-Poch, M.S. Fortes-González
Читать у издателя →
Цитирование
Rituximab in treatment-resistant anti-HMG-CoA reductase immune-mediated necrotising myopathy. // Neurología (English Edition). – URL: https://www.sciencedirect.com/science/article/pii/S2173580826000945?dgcid=rss_sd_all
Rituximab in treatment-resistant anti-HMG-CoA reductase immune-mediated necrotising myopathy. Neurología (English Edition). https://www.sciencedirect.com/science/article/pii/S2173580826000945?dgcid=rss_sd_all
“Rituximab in treatment-resistant anti-HMG-CoA reductase immune-mediated necrotising myopathy.” Neurología (English Edition).
@article{article59856,
title = {Rituximab in treatment-resistant anti-HMG-CoA reductase immune-mediated necrotising myopathy},
journal = {Neurología (English Edition)},
url = {https://www.sciencedirect.com/science/article/pii/S2173580826000945?dgcid=rss_sd_all}
}